3 Results for "

JNJ-1013

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "JNJ-1013" in MCE Product Catalog:

Cat. No.: HY-153188
CAS No.: 2597343-08-1
Purity:  99.80%
Target:  

PROTACs Apoptosis IRAK

Research Areas:  

Cancer

JNJ-1013 is a potent and selective IRAK1 PROTAC degrader with an IC50s of 72, 443, 1071 nM for IRAK1, IRAK4, VHL FP respectively. JNJ-1013 induces apoptosis and increases the expression of cleavaged PARP. JNJ-1013 decreases the expression IRAK1, p-IKBα, pSTAT3(Tyr705) (Pink: ligand for target protein (HY-138834); black: linker (HY-Y1760); Blue: E3 ligase ligand (HY-112078)) .
loading...
    loading...
Cat. No.: HY-153188A
CAS No.: 2755075-91-1
Target:  

Drug Isomer IRAK PROTACs

Research Areas:  

Cancer

(S)-JNJ-1013 is an isomer of IRAK1 PROTAC degrader JNJ-1013 (HY-153188). (S)-JNJ-1013 loses VHL binding affinity (IC50 >10 μM) and shows no significant IRAK1 degradation activity (DC50 > 10 μM). (S)-JNJ-1013 selectively inhibits IRAK1 with an IC50 of 79 nM. (S)-JNJ-1013 can be used to study cancers dependent on the scaffolding function of IRAK1 .
loading...
    loading...
Cat. No.: HY-169970
Research Areas:  

Cancer

Me-(S,R,S)-AHPC-CO-CH2-Br is an E3 ligase ligand-linker conjugate. Me-(S,R,S)-AHPC-CO-CH2-Br can be used to synthesize JNJ-1013 (HY-153188) .
loading...
    loading...